What is Topotecan Eagle?
This is a summary of the European public assessment longerreport (EPAR) for TopotecanauthorisedEagle. It explains how the Committee for Medicinal Products for Human Use (CHMP) ass ssed the medicine to reach its
opinion in favour of granting a marketing authorisation and its comm ndations on the conditions of use for Topotecan Eagle.
no Topotecan Eagle is a medicineProductthat contains he active substance topotecan. It is available as a concentrate to be made up into a solution for infusion (drip into a vein).
Topotecan Eagle is a ‘hybrid generic medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance. While the reference medicine, Hycamtin, is available as a powder to be made up into a ncentrate, Topotecan Eagle is available as a
WhatMedicinalis Topotecan Eagle used for?
Topotecan Eagle s an anticancer medicine. It is used on its own to treat patients with small cell lung cancer, when the ancer has relapsed (come back). It is used when giving the original treatment again
is not recommended.
It is also us together with cisplatin (another anticancer medicine) to treat women with cancer of the cervix, when the cancer has come back after radiotherapy, or when the disease is at an advanced stage (stage IVB: the cancer has spread beyond the cervix).
The medicine can only be obtained with a prescription.